UPR

Systems Oncology to Present Positive Preclinical Data for SERA2 at J.P. Morgan 41st Annual Healthcare Conference

Retrieved on: 
Tuesday, December 6, 2022
Oncology, Health, Health Technology, Research, Science, Pharmaceutical, Biotechnology, ER, Chemistry, Baylor University Medical Center, UPR, Champaign County, Illinois, Oncology, J. P. Morgan, Intellectual property, IP, Patient, SERA, Research, Biology, Breast cancer, SO, Aromatase, Unfolded protein response, Selective estrogen receptor degrader, McKesson Corporation, Cell death, University, Selective estrogen receptor modulator, Medical imaging, Pharmaceutical industry

Systems Oncology today announced they will be presenting positive preclinical data on the companys next generation estrogen receptor positive drug candidate, SERA2 (Selective Estrogen Receptor Activator).

Key Points: 
  • Systems Oncology today announced they will be presenting positive preclinical data on the companys next generation estrogen receptor positive drug candidate, SERA2 (Selective Estrogen Receptor Activator).
  • In the preclinical data presented at J.P. Morgan, treatment with SERA2 in animal models of human breast cancer results in multiple, complete, durable tumor regressions.
  • These data support the rationale for SERA2 as a novel therapeutic for the treatment of breast cancer and potentially other estrogen receptor positive cancers.
  • Systems Oncology will be having partnering meetings during the J.P. Morgan conference from January 9 to January 11, 2023.

1,4-Butanediol Market Global Key Players, Demands, Sales, Growth rate, Size, Share and Forecast to 2027 - ReportsnReports

Retrieved on: 
Tuesday, November 22, 2022
Adhesive, Plastic, Research report, Growth, Database, Environment, Government, Copolymer, Region, Climate, UPR, THF, PVC, BASF SE, Textile, USD, DCC, BDO, SE, BASF, Renewable energy, Lithium, Accounting, Benzene

The global 1,4-Butanediol market size is estimated to be USD 7.3 billion in 2022 and projected to reach USD 11.0 billion by 2027, at a CAGR of 8.5%.

Key Points: 
  • The global 1,4-Butanediol market size is estimated to be USD 7.3 billion in 2022 and projected to reach USD 11.0 billion by 2027, at a CAGR of 8.5%.
  • The growing awareness regarding recyclable products, and their benefits related to the environment is one the primary factors driving market growth.
  • Moreover, factors like growing demand from the automotive industry, and high demand from the textile sector are also contributing toward the market growth of 1,4-Butanediol.
  • Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

PureCycle Technologies Provides Third Quarter 2022 Update

Retrieved on: 
Wednesday, November 9, 2022
SK, Orlando Magic, Company, COVID-19, Review, Cincinnati Bengals, Sale, UPR, Trustee, Partnership, Development, NASDAQ, MOU, Transport, Water, Bond, Growth, Raw material, Engineering, Letter of intent, PP, Mississippi River, LOI, Recycling, Renewable energy, Oil, Central Florida

ORLANDO, Fla., Nov. 9, 2022 /PRNewswire/ -- PureCycle Technologies, Inc. ("PureCycle" or "the Company") (NASDAQ: PCT), a U.S.-based company revolutionizing plastic recycling, today announced a corporate update and financial results for the third quarter ending September 30, 2022.

Key Points: 
  • ORLANDO, Fla., Nov. 9, 2022 /PRNewswire/ -- PureCycle Technologies, Inc. ("PureCycle" or "the Company") (NASDAQ: PCT), a U.S.-based company revolutionizing plastic recycling, today announced a corporate update and financial results for the third quarter ending September 30, 2022.
  • Dustin Olson, PureCycle's Chief Executive Officer, said, "The PureCycle team continued to make significant progress in executing the Company's strategic growth plans during the third quarter.
  • PureCycle had $233.3 million in debt and accrued interest, less $16.3 million of discount and issuance costs as of September 30, 2022.
  • ET to provide an update on recent corporate developments, including activity from the third quarter and updated future strategic plans.

HiberCell to Present Preclinical Data from Novel GCN2 Activator and PERK Inhibitor Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

Retrieved on: 
Wednesday, November 2, 2022
ISR, ER, Unfolded protein response, SITC, GLOBE, Intelligence, UPR, Cell, Immunotherapy, Annual general meeting, Patient, Machine learning, Metastasis, Neoplasm, 2021 Essex County Council election, Therapy, Society, GCN2, Society for Immunotherapy of Cancer, Pharmaceutical industry

Full text of the abstracts will be available on the SITC website at 8:00 a.m.

Key Points: 
  • Full text of the abstracts will be available on the SITC website at 8:00 a.m.
  • PERK is part of the unfolded protein response (UPR) that is activated in cancer cells by accumulation of misfolded proteins in the ER and enables their adaptive survival mechanism.
  • HiberCell is currently conducting Phase 1 clinical trials in solid tumors for each of our therapeutic candidates HC-7366 (NCT05121948) and HC-5404 (NCT04834778).
  • HiberCell is a clinical-stage biotechnology company dedicated to the advancement of novel therapeuticagentstargeting adaptive stress pathways and immune modulation to enable patients to live longer, cancer-free lives.

Orlando Magic Advance Sustainability Efforts with PureCycle's PureZero™ Program

Retrieved on: 
Wednesday, November 2, 2022
Orlando Magic, Growth, Annual report, Risk, NBA G League, G-League, Conference, Amway Center, SEC, Gambling in Thailand, Industry, U.S. Securities and Exchange Commission, UPR, NHL, Public expenditure, Sport, NBA 2K League, Technology, Orlando Solar Bears, Devos, Season, NBA, P&G, Advance Publications, Magic, Multimedia, Procter & Gamble, ECHL, Forward-looking statement, Glossary of cue sports terms, 3D printing, Recycling, Risk management, Marketing

5 plastic waste resulting in an ultra-pure recycled (UPR) plastic can be recycled and reused multiple times, changing our relationship with plastic.

Key Points: 
  • 5 plastic waste resulting in an ultra-pure recycled (UPR) plastic can be recycled and reused multiple times, changing our relationship with plastic.
  • Off the court, on an annual basis, the Orlando Magic gives more than $2 million to the local community by way of sponsorships of events, donated tickets, autographed merchandise and grants.
  • Orlando Magic community relations programs impact an estimated 100,000 kids each year, while a Magic staff-wide initiative provides more than 7,000 volunteer hours annually.
  • In addition, the Orlando Magic Youth Foundation (OMYF) which serves at-risk youth, has distributed more than $27 million to local nonprofit community organizations over the last 32 years.

PureCycle, League of Women Voters Partner in Nonpartisan Effort to Clean Up and Recycle Campaign Signs

Retrieved on: 
Tuesday, November 1, 2022
Growth, Annual report, Risk, Color, SEC, Gambling in Thailand, Industry, U.S. Securities and Exchange Commission, UPR, Public expenditure, Technology, P&G, Multimedia, Procter & Gamble, Forward-looking statement, Recycling, Risk management, Marketing

ORLANDO, Fla., Nov. 1, 2022 /PRNewswire/ -- PureCycle Technologies, Inc. (NASDAQ: PCT) is announcing today its plans to work with the League of Women Voters (LWV) of Volusia, Seminole, and Orange Counties to collect and recycle over 15,000 political signs in Central Florida after the November 8th midterm elections. This joint effort is expected to divert up to 10,000 pounds of plastic waste from Florida landfills, waterways, and green spaces, protecting the local environment and making Florida's 2022 election cycle more sustainable.

Key Points: 
  • The unique purification process is designed to remove color, odor, and other impurities from No.
  • 5 plastic waste resulting in an ultra-pure recycled (UPR) plastic that can be recycled and reused over and over again, changing our relationship with plastic.
  • www.purecycle.com
    This press release contains forward-looking statements, including statements about the financial condition, results of operations, earnings outlook and prospects of PureCycle.
  • In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements.

Milliken and PureCycle advance circularity by launching new concentrate using recycled PP resin

Retrieved on: 
Friday, October 21, 2022
LinkedIn, U.S. Securities and Exchange Commission, Color, Milliken & Company, Procter & Gamble, SEC, Carbon footprint, GHG, Growth, PP, Science, P&G, Annual report, NASDAQ, Plastic, Olson, RPP, NX, Carbon, Procter and Gamble Baltimore Plant, Twitter, Recycling, Instagram, Partnership, Technology, UPR, Goal, Company, Industry, Chemistry, Public expenditure, Forward-looking statement, Gambling in Thailand, Solution, Risk, Fine chemical, Risk management, Marketing, Online gambling, Facebook

This development advances circularity, since the concentrate based on PureCycle materials will allow for greater use of 100% recycled content.

Key Points: 
  • This development advances circularity, since the concentrate based on PureCycle materials will allow for greater use of 100% recycled content.
  • Today's announcement of the first odorless concentrate for PP based on a recycled resin carrier was a direct result of that collaboration.
  • The game-changing technology separates color, odor and other contaminants from PP waste feedstock to transform it into ultra-pure, virgin-like resin.
  • Milliken's technical leadership and top-tier additives play a critical role in reinvigorating recycled polypropylene (rPP) for PureCycle.

PureCycle Technologies, Inc. and SK geo centric Invest in Building First Polypropylene Recycling Plant in Asia

Retrieved on: 
Thursday, October 20, 2022
U.S. Securities and Exchange Commission, Color, Procter & Gamble, SEC, Growth, P&G, Annual report, Plastic, SK, Multimedia, Technology, UPR, Industry, Better Life, Public expenditure, Forward-looking statement, Gambling in Thailand, Solution, Risk, Marketing, Recycling, Risk management, Online gambling

In 1972, SK geo centric laid the foundation for the development of the petrochemical industry by operating the first naphtha-cracking facility in Korea.

Key Points: 
  • In 1972, SK geo centric laid the foundation for the development of the petrochemical industry by operating the first naphtha-cracking facility in Korea.
  • SK geo centric provides various automotive & packaging products and solutions that customers and markets require.
  • Furthermore, SK geo centric is growing into a technology-based global chemical company through continuous R&D efforts and global expansion.
  • SK geo centric will achieve its vision,'Green for Better Life', by establishing a plastics based circular economy by collaborating with various partners and stakeholders.

PureCycle Technologies Schedules Third Quarter 2022 Corporate Update Conference Call for Thursday, November 10, 2022, at 11:00 a.m. ET

Retrieved on: 
Monday, October 17, 2022
UPR, P&G, Color, Procter & Gamble, Technology

The webcast platform will register your name and organization as well as provide dial-ins numbers and a unique access pin.

Key Points: 
  • The webcast platform will register your name and organization as well as provide dial-ins numbers and a unique access pin.
  • If you have any difficulty connecting with the conference call, please contact PureCycle Investor Relations at (689) 233-3595.
  • A replay of the conference call will be available after 2:00 p.m. Eastern time on the same day through November 10, 2023.
  • 5 plastic waste resulting in an ultra-pure recycled (UPR) plastic that can be recycled and reused over and over again, changing our relationship with plastic.

Bold Therapeutics Attending and Presenting at the BIO-Europe 2022 and BIO-Europe 2022 Virtual Conferences

Retrieved on: 
Friday, October 14, 2022
GRP78, Therapy, Conference, ASCO, Society, Patient, Induced cell cycle arrest, Unfolded protein response, Confidentiality, Annual general meeting, Multimedia, UPR, Cell death, ROS, Gastrointestinal cancer, Reactive oxygen species, DNA, FOLFOX, Breakthrough therapy, Cancer, View, DNA repair, Pharmaceutical industry, BC

VANCOUVER, BC, Oct. 14, 2022 /PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company, announced that they are attending the BIO-Europe 2022 conference in Leipzig, Germany from October 24 26, as well as presenting at the BIO-Europe Virtual Conference from November 2 - 4.

Key Points: 
  • VANCOUVER, BC, Oct. 14, 2022 /PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company, announced that they are attending the BIO-Europe 2022 conference in Leipzig, Germany from October 24 26, as well as presenting at the BIO-Europe Virtual Conference from November 2 - 4.
  • Bold Therapeutics presented initial data from this Phase 2 trial at the 2022 American Society of Cancer Oncology (ASCO) Annual Meeting in June 2022.
  • Consequently, Bold Therapeutics expects to receive a Breakthrough Therapy Designation in the treatment of 3rd line or later treatment-resistant metastatic colorectal cancer (mCRC) and potentially other gastrointestinal cancer indications as well.
  • Bold Therapeutics expects to present this robust data set at a major cancer conference in early 2023.